- Home
- MCBS vs QURE Comparison
MCBS vs QURE Comparison
Compare MCBS & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCBS
- QURE
- Stock Information
- Founded
- MCBS 2006
- QURE 1998
- Country
- MCBS United States
- QURE Netherlands
- Employees
- MCBS N/A
- QURE N/A
- Industry
- MCBS Major Banks
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- MCBS Finance
- QURE Health Care
- Exchange
- MCBS Nasdaq
- QURE Nasdaq
- Market Cap
- MCBS 745.5M
- QURE 725.4M
- IPO Year
- MCBS 2019
- QURE 2007
- Fundamental
- Price
- MCBS $27.08
- QURE $14.21
- Analyst Decision
- MCBS Hold
- QURE Strong Buy
- Analyst Count
- MCBS 1
- QURE 10
- Target Price
- MCBS $34.00
- QURE $37.20
- AVG Volume (30 Days)
- MCBS 30.6K
- QURE 1.2M
- Earning Date
- MCBS 07-18-2025
- QURE 07-31-2025
- Dividend Yield
- MCBS 3.38%
- QURE N/A
- EPS Growth
- MCBS 30.91
- QURE N/A
- EPS
- MCBS 2.58
- QURE N/A
- Revenue
- MCBS $143,775,000.00
- QURE $20,201,000.00
- Revenue This Year
- MCBS $16.00
- QURE $27.16
- Revenue Next Year
- MCBS $31.75
- QURE $248.21
- P/E Ratio
- MCBS $10.42
- QURE N/A
- Revenue Growth
- MCBS 19.70
- QURE 6.30
- 52 Week Low
- MCBS $24.00
- QURE $3.73
- 52 Week High
- MCBS $36.15
- QURE $19.18
- Technical
- Relative Strength Index (RSI)
- MCBS 42.39
- QURE 44.61
- Support Level
- MCBS $27.14
- QURE $14.75
- Resistance Level
- MCBS $28.90
- QURE $15.35
- Average True Range (ATR)
- MCBS 0.57
- QURE 1.05
- MACD
- MCBS -0.12
- QURE -0.27
- Stochastic Oscillator
- MCBS 14.55
- QURE 10.79
About MCBS MetroCity Bankshares Inc.
MetroCity Bankshares Inc is a holding company of its subsidiary Metro City Bank. It provides commercial banking services such as consumer and commercial checking accounts, savings accounts, certificates of deposits, commercial and consumer loans, money transfers and a variety of other banking services. The banks generate revenue from interest income. Its customers include small business owners, professionals, consumers, and real estate developers.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.